XILONG SCIENTIFIC(002584)
Search documents
西陇科学(002584) - 2015年8月27日投资者关系活动记录表
2022-12-07 08:31
证券代码:002584 证券简称:西陇化工 西陇化工股份有限公司投资者关系活动记录表 编号:20150801 | --- | --- | --- | |----------------|-----------------------------|-----------------------------------------| | | | | | 投资者关系活动 | ■ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 上海汇利资产 叶丽 | | | 人员姓名 | 瑞锐投资 陆慧 | | | | 深圳卓越鼎盛 冯超、王嘉睎 | | | | 中海基金 易小金 | | | | 北京宏道投资 张海滨 | | | | 中国健康产业投资基金 应振洲 | | | | 中国人寿资产 丁天宇 | | | | | 华泰证券 杨烨辉、肖汉山、陈虹妃、朱荣钊 | | | 广东新价值 林帅 | | | | 九泰基金 林柏川 | | | | ...
西陇科学(002584) - 2016年1月4日投资者关系活动记录表
2022-12-06 11:18
证券代码:002584 证券简称:西陇科学 西陇科学股份有限公司投资者关系活动记录表 编号:20151101 | --- | --- | --- | |----------------|-------------------------------|----------------------------------------------------| | | | | | 投资者关系活动 | ■ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 太平洋证券 杨林 | | | 人员姓名 | | | | 时间 | 2016 年 1 月 4 | 日 14:00-16:00 | | 地点 | 董事会秘书办公室 | | | 上市公司接待人 | 邬军晖 | | | 员姓名 | 莫娇 | | | | 1. 公司的历史和发展过程简介 | | | | | 公司正在进行生产模式的转变,从传统的生产型企业转向 | | | | 轻资产的生产 ...
西陇科学(002584) - 2016年5月24日投资者关系活动记录表
2022-12-06 09:01
证券代码:002584 证券简称:西陇科学 西陇科学股份有限公司投资者关系活动记录表 编号:20160501 | --- | --- | --- | |----------------|------------------------------|---------------------------------| | | | | | 投资者关系活动 | ■ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 澳银资本 纪昌涛 | | | 人员姓名 | 国都证券 赵玥 | | | | 广州证券 邓照 | | | | 通晟资产 张烨 | | | | 华创证券 王逸萌 | | | | 华创证券 宋凯 | | | | 中科沃土基金 孟禄程 | | | | 广东瑞天投资 王贤 | | | | 广发基金 王瑞冬 | | | | 广发资管 毛丁丁 | | | 时间 | 2016 年 5 月 24 日 | 13:30-15:30 | ...
西陇科学(002584) - 西陇科学调研活动信息
2022-12-03 08:36
证券代码:002584 证券简称:西陇科学 西陇科学股份有限公司投资者关系活动记录表 编 号 : 20201222 | --- | --- | --- | |-----------------------|-----------------------------|----------------------------------------------------| | | | | | | ■ | 特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 华泰证券 王玮嘉 陆晓霞 | | | 人员姓名 | | | | | | | | 时间 | 2020 年 12 月 22 | 日 10: 15 - 12 : 00 | | 地点 | 公司 5 楼会议室 | | | 上市公司接待人 员姓名 | 宗岩 | | | | 1. 公司所处行业发展情况? | | | | | (1)化学试剂行业的一个重要特点是品种多,工艺技术 | | ...
西陇科学(002584) - 2022年广东辖区上市公司投资者网上集体接待日活动记录表
2022-11-11 07:35
证券代码:002584 证券简称:西陇科学 编号:2022-02 西陇科学股份有限公司 投资者活动记录表 | --- | --- | --- | |-----------------------------|--------------------------------------------------|----------------------------------------------------------------------------------------------------| | | □特定对象调研 □分析师会议 | | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | □电话会议 | | | √其他: 2022 | 广东辖区上市公司投资者网上集体接待日 | | 参与单位名称 及人员姓名 | 西陇科学 2022 远程方式进行,面向全体投资者 | 广东辖区上市公司投资者网上集体接待日活动采用网络 | | 时间 | 2022 年 9 月 22 日 15:50-16:50 | | | 地点 | 全景网 | ...
西陇科学(002584) - 2022 Q3 - 季度财报
2022-10-27 16:00
西陇科学股份有限公司 2022 年第三季度报告 证券代码:002584 证券简称:西陇科学 公告编号:2022-062 西陇科学股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 西陇科学股份有限公司 2022 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | --- | --- | --- | --- | --- | |-----------------------------------------------------|------------------|-------------------------|----------- ...
西陇科学(002584) - 2022 Q2 - 季度财报
2022-08-14 16:00
西陇科学股份有限公司 2022 年半年度报告全文 西陇科学股份有限公司 2022 年半年度报告 1 西陇科学股份有限公司 2022 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担 个别和连带的法律责任。 公司负责人黄少群、主管会计工作负责人王庆东及会计机构负责人(会计 主管人员)王庆东声明:保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 如半年度报告涉及未来计划等前瞻性描述,该计划不构成公司对投资者 的实质承诺,投资者及相关认识均应当对此保持足够的风险认识,并且应当 理解计划、预测和承诺之间的差异。 公司面临宏观经济波动风险、安全生产的风险、环保风险、技术研发风 险以及管理风险等,敬请广大投资者注意投资风险。 公司计划不派发现金红利,不送红股,不以公积金转增股本。 2 西陇科学股份有限公司 2022 年半年度报告全文 目录 | --- | --- | |-----------------------------------|------ ...
西陇科学(002584) - 2022 Q1 - 季度财报
2022-04-27 16:00
Financial Performance - The company's revenue for Q1 2022 was ¥1,838,144,076.52, representing a 16.24% increase compared to ¥1,581,356,349.46 in the same period last year[3] - Net profit attributable to shareholders reached ¥83,755,330.19, a significant increase of 505.07% from ¥13,842,141.69 in the previous year[3] - Basic earnings per share increased to ¥0.14, up 600.00% from ¥0.02 in the same period last year[3] - Total operating revenue for the first quarter reached ¥1,838,144,076.52, an increase of 16.3% compared to ¥1,581,356,349.46 in the previous year[25] - Net profit for the period was ¥83,957,732.37, significantly higher than ¥11,861,247.73 in the same quarter last year, marking a substantial increase[28] - The total comprehensive income for the period was ¥83,938,253.21, compared to ¥11,549,352.03 in the previous year, showing a strong performance[30] Cash Flow - The net cash flow from operating activities decreased by 70.02% to ¥12,699,955.54, down from ¥42,357,886.65 in the previous year[3] - The net cash flow from operating activities for the current period is ¥12,699,955.54, a decrease of 70% compared to ¥42,357,886.65 in the previous period[35] - The cash outflow from operating activities totals ¥2,133,909,033.81, compared to ¥1,682,987,659.80 in the previous period, indicating higher operational expenses[35] - The net cash flow from investment activities improved to ¥282,179,941.84 from -¥19,932,086.14 in the previous period, indicating a positive turnaround in investment performance[35] - The total cash inflow from investment activities is ¥389,951,398.69, significantly higher than ¥40,195,070.14 in the previous period[35] - The net cash flow from financing activities is -¥194,630,992.88, compared to -¥173,727,365.04 in the previous period, indicating increased cash outflows[35] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,696,696,552.69, a slight decrease of 0.58% from ¥4,724,032,726.87 at the end of the previous year[3] - The company's total liabilities decreased to ¥2,365,626,894.65 from ¥2,402,156,073.62, a reduction of approximately 1.5%[24] - The total equity attributable to shareholders of the parent company rose to ¥2,325,456,355.60, compared to ¥2,241,063,958.72, indicating an increase of about 3.5%[24] - The company's equity attributable to shareholders increased by 3.77% to ¥2,325,456,355.60 from ¥2,241,063,958.72 at the end of the previous year[3] - The total non-current assets decreased to ¥1,020,143,496.87 from ¥1,153,806,494.39 at the beginning of the year[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 92,999, with the top ten shareholders holding a combined 55.31% of shares[11] - Huang Shaoqun holds 12.73% of shares, with a total of 74,500,000 shares, and has 7,760,000 shares frozen[11] Investment and Development - Investment income surged to ¥72,607,438.26, a remarkable increase of 78303.01% compared to ¥92,607.97 in the previous year[9] - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[27] Tax and Expenses - The company experienced a 371.53% increase in income tax expenses, totaling ¥7,365,387.45, due to the growth in total profit[9] - The company paid ¥22,031,989.51 in taxes, down from ¥49,655,724.82 in the previous period, showing a reduction in tax liabilities[35] Inventory and Current Assets - The company's total current assets amount to ¥3,676,553,055.82, an increase from ¥3,570,226,232.48 at the beginning of the year[15] - Cash and cash equivalents at the end of the reporting period are ¥846,761,942.70, up from ¥769,862,949.87 at the beginning of the year[15] - Accounts receivable stand at ¥1,243,736,953.53, compared to ¥1,212,893,151.92 at the start of the year[15] - Inventory has increased to ¥697,589,849.59 from ¥454,424,458.43 at the beginning of the year[18]
西陇科学(002584) - 2021 Q4 - 年度财报
2022-04-21 16:00
Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year increase of 15%[23]. - The net profit attributable to shareholders was RMB 200 million, an increase of 10% compared to the previous year[23]. - The company's operating revenue for 2021 was ¥6,837,667,633.82, representing a 9.52% increase from ¥6,243,170,933.20 in 2020[6]. - The net profit attributable to shareholders in 2021 was ¥203,877,034.92, a significant increase of 258.47% compared to ¥56,873,463.11 in 2020[6]. - The net cash flow from operating activities was ¥346,617,647.91, marking a 677.67% increase from ¥44,571,222.05 in 2020[6]. - The company reported a significant increase in financial expenses by 66.55% to approximately ¥67.75 million, primarily due to reduced interest income and increased exchange losses[82]. - The company reported a total of 329,793,075.09 yuan in financial assets at the end of the reporting period, with significant transactions in trading financial assets and other equity investments[120]. Research and Development - The company plans to invest RMB 300 million in research and development for new products and technologies in 2022[23]. - Research and development expenses rose by 15.82% to approximately ¥118.97 million, reflecting the company's commitment to innovation[82]. - The company has initiated several key R&D projects aimed at enhancing the purity of electronic chemical products, which are currently in the pilot testing phase[104]. - The company has been awarded 21 patents for general chemical reagents and 13 patents for electronic chemicals, indicating strong R&D capabilities[69]. - The company achieved significant product development, including the mass production of lithium-ion battery adhesives and environmentally friendly high-purity potassium persulfate, with a purity specification of 99.5% HPLC for organic pharmaceutical intermediates[63]. Market Expansion and Strategy - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 20% market share in the region by 2025[23]. - The company expects a revenue growth forecast of 18% for 2022, driven by new product launches and market expansion efforts[23]. - The company is focusing on the semiconductor and new energy materials sectors, aligning with the "carbon neutrality" strategy for high-quality development[62]. - The company is actively adjusting its product structure and optimizing production processes to meet stricter environmental standards and reduce emissions[143]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market presence[23]. Operational Efficiency - The gross margin for the year was reported at 35%, a slight decrease from 37% in the previous year[23]. - The company reported a net profit margin of 12%, up from 10% in the previous year, indicating improved operational efficiency[182]. - The company aims to enhance management efficiency and reduce costs while improving product quality and delivery times through internal management improvements[136]. - The company has established a governance structure that operates independently from its controlling shareholders[162]. User and Market Data - User data showed a growth of 25% in active users of the company's e-commerce platform, reaching 1 million users by the end of 2021[23]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year, representing a 20% year-over-year growth[182]. - Market expansion efforts have led to a 10% increase in sales in international markets, totaling 300 million RMB[182]. Corporate Governance - The company has held one annual general meeting and six extraordinary general meetings during the reporting period, ensuring compliance with legal and regulatory requirements[151]. - The board of directors has completed a re-election process, maintaining a structure that complies with legal requirements and includes independent directors[152]. - The company has established a dedicated audit department to conduct regular financial audits in accordance with regulatory guidelines[155]. Asset Management - The total assets at the end of 2021 were ¥4,724,032,726.87, which is a 6.84% increase from ¥4,421,453,856.17 at the end of 2020[6]. - The company’s inventory decreased significantly from CNY 713,335,682.26 at the beginning of 2021 to CNY 454,424,458.43 at the end of the year, reflecting a reduction of 6.51% in its proportion of total assets[116]. - The company has a total of 363,512,479.28 yuan in restricted assets at the end of the reporting period, including 279,454,686.71 yuan in cash and 20,000,000.00 yuan in accounts receivable[123]. Compliance and Regulations - The company has received multiple licenses and certifications, including hazardous chemical operation permits, ensuring compliance with regulatory standards[76]. - The company reported a total of 118 announcements during the reporting period, ensuring compliance with information disclosure regulations[158].
西陇科学(002584) - 2021 Q3 - 季度财报
2021-10-25 16:00
西陇科学股份有限公司 2021 年第三季度报告 证券代码:002584 证券简称:西陇科学 公告编号:2021-058 西陇科学股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的 真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |------------------------------------------------------|------------------|-------------------------|--------------------------|----------- ...